Summary Safety Review – Gadolinium based contrast agents – Assessing the risk of gadolinium build-up in the brain and potential brain and nervous system (neurological) side effects

Health Canada In 2016, Health Canada reviewed the risk of gadolinium build-up in the brain and the unknown potential neurological side effects because some published studies showed that gadolinium may stay in the brain when GBCAs are given repeatedly. Health Canada’s review concluded that the risk of gadolinium build-up in the brain is higher with […]